Hubei Guangji Pharmaceutical Co., Ltd.

SZSE:000952 Stock Report

Market Cap: CN¥2.2b

Hubei Guangji Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Subdued Growth No Barrier To Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Price

Oct 28
Subdued Growth No Barrier To Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Price

Benign Growth For Hubei Guangji Pharmaceutical Co., Ltd. (SZSE:000952) Underpins Stock's 30% Plummet

Jun 07
Benign Growth For Hubei Guangji Pharmaceutical Co., Ltd. (SZSE:000952) Underpins Stock's 30% Plummet

There's No Escaping Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Muted Revenues Despite A 28% Share Price Rise

Mar 08
There's No Escaping Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Muted Revenues Despite A 28% Share Price Rise

CEO

Hubei Guangji Pharmaceutical has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Shao Zhi Guo
Deputy GM & Directorno dataCN¥492.20k0.070%
CN¥ 1.5m
Bin Zheng
Board Secretary4.6yrsCN¥475.40k0.063%
CN¥ 1.4m
Zhong Yi Ruan
Deputy General Manager2.7yrsCN¥489.00k0.066%
CN¥ 1.4m
Xin Wang
Deputy General Managerno dataCN¥461.80k0.069%
CN¥ 1.5m
Mingfeng Hu
Deputy General Managerless than a yearCN¥525.00k0.063%
CN¥ 1.4m
Zhengdong Lu
Deputy General Managerno dataCN¥522.00k0.069%
CN¥ 1.5m
Yi Xiong
Chief Financial Officerless than a yearno datano data
Qiong Wang
Accounting Supervisorno datano datano data

1.8yrs

Average Tenure

54yo

Average Age

Experienced Management: 000952's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shao Zhi Guo
Deputy GM & Director3.8yrsCN¥492.20k0.070%
CN¥ 1.5m
Bo Liu
Non-Independent Director3.8yrsno datano data
Kui Hong
Independent Director3.8yrsCN¥71.40kno data
Jianming Mei
Independent Director3.8yrsCN¥71.40kno data
Tao Jiang
Non-Employee Supervisor7yrsno datano data
Shasha Zhang
Member of Supervisory Board2.8yrsno datano data
Weining Tong
Directorno datano datano data
Shoudong Shi
Non-Independent Directorless than a yearno datano data
Ligang Hu
Non-Independent Directorless than a yearno datano data
Cheng Gong
Non-Independent Directorless than a yearno datano data
Zhi Fang
Non-Independent Directorless than a yearno datano data
Wei Guo
Independent Directorless than a yearno datano data

2.8yrs

Average Tenure

48yo

Average Age

Experienced Board: 000952's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 16:22
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Guangji Pharmaceutical Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peng YanChangjiang Securities Co. LTD.
Jie YaoCitic Securities Co., Ltd.
Xi LiuHuatai Research